News

Website-Relaunch of Dr. Erkens Consulting Group

We have used the summer vacation and the current restrictions due to the Covid-19 pandemic to completely redesign our website and provide it with new content.

The website of the Dr. Erkens Consulting Group officially goes online on 03 September 2020, and in addition to corporate information about the Dr. Erkens Consulting Group and its range of services it offers many other features such as current information from the health industry, regular blog posts on topics relating to marketing and sales, and much more.

We have been supported in the creation of our new and completely responsive website by our longstanding partner be-sign.net.

Integrated Pharma-News at Dr. Erkens Consulting Group Website

As a strategy and consulting agency, we always need to be up to date. A large number of internet portals in the areas of healthcare, medicine, pharmaceuticals, biotech, medtech and life sciences are currently available. However, these areas are so large and evolve so rapidly that none of these portals alone can provide information about all the innovations. We therefore decided to provide links on our website to a number of selected news portals in order to keep you and us up to date with regard to indications, new diagnostic methods, therapies, market and company changes, trends, and much more.

Adress

Dr. Erkens Consulting Group
Industriestraße 13
64380 Roßdorf
Tel: +49 (0)6154 – 6967 – 944
Mobil +49 (0)179 – 2 41 10 29
info@dr-erkens-consulting.de

Social

News

Dr. Erkens Consulting Group

Website-Relaunch of Dr. Erkens Consulting Group
Source: Dr. Erkens Consulting Group 09/2020
Integrated Pharma-News at Dr. Erkens Consulting Group Website
Source: Dr. Erkens Consulting Group 09/2020

Pharma Letter

Organon and Samsung look for edge in battle of the biosimilars
Source: Pharma Letter Published on 2023-09-01
Russian drugmaker R-Pharm eyes buying Takeda plant in Yaroslavl
Source: Pharma Letter Published on 2023-08-30
FibroGen stock slumps 22% as DMD candidate fails in Phase III
Source: Pharma Letter Published on 2023-08-30
Kyowa Kirin picks up Japanese approval for Orkedia
Source: Pharma Letter Published on 2023-08-30
Injectable Tecentriq wins first approval from British regulator
Source: Pharma Letter Published on 2023-08-29

Pharma Relations

#Wachbeben in Deutschland
Source: Pharma Relations Published on 2024-02-07
"isla" gibt sozialen Projekten eine Stimme
Source: Pharma Relations Published on 2024-02-06
TK bietet psychoonkologische Unterstützung durch Living Well Plus-App
Source: Pharma Relations Published on 2024-02-06
DP-Medconnect mit neuer Führung
Source: Pharma Relations Published on 2024-02-06
Wort & Bild übernimmt das Fachmagazin "PTA Woman"
Source: Pharma Relations Published on 2024-02-06

Pharma Times

New clinical trial aims to investigate skin patches to spot lung transplant rejection
Source: Pharma Times Published on 2024-04-19
CureVac and MD Anderson Cancer Center partner to develop new cancer vaccines
Source: Pharma Times Published on 2024-04-19
Researchers introduce new AI tool to help clinicians capture uncertainty in medical images
Source: Pharma Times Published on 2024-04-18
New UK report highlights inequalities among people living with breast cancer
Source: Pharma Times Published on 2024-04-18
ELRIG UK and SRG collaborate to advance life sciences professionals in drug discovery
Source: Pharma Times Published on 2024-04-17

PZ online

Thüringer Apothekertag: Regionale Lösungen finden
Source: PZ online Published on 2024-04-19
Beschleunigte Zulassung: Klinischer Nutzen neuer Krebsmedikamente oft geringer als erwartet
Source: PZ online Published on 2024-04-19
Großbritannien: Brexit verschärft Arzneimittelknappheit
Source: PZ online Published on 2024-04-18
Laborwerte: Wichtige Akteure des Eisenstoffwechsels
Source: PZ online Published on 2024-04-18
Medikationsmanagement: Psychiatrische Patienten optimal betreuen
Source: PZ online Published on 2024-04-17

Our Place on Earth

Kartenbild: OpenStreetMap, ODbL 1.0